Replies to post #122459 on Biotech Values

[piggerpig]

Thanks for the replay!
I only had 3k shares - bought a small starter position just to check it out (thanks).
So I sold yesterday because I didnt have a strong feeling, and it is only vague talks.
I agree the market cap is so miniscule that PFE can pay pretty much any multiple of current cap. I however have no idea what/why PFE is looking for here so I sold.
Ill be glad to revisit if more info comes to light or I understand more about ICGN.
Thanks again.

[bladerunner1717]

PFE to acquire ICGN...for $6/share!!

The stock is down 23% in pre-market. Yesterday the stock hit $8.40. I don't get this. I think a lawsuit has already been filed. ICGN shareholders have got to be disappointed. I'm sure they were expecting a higher buyout price.


BOSTON | Wed Jul 20, 2011 9:03am EDT

(Reuters) - Pfizer Inc (PFE.N) said on Wednesday it has agreed to acquire Icagen Inc (ICGN.O), which is developing drugs to treat pain and related disorders.

Pfizer already owns about 11 percent of Icagen. It will acquire the remaining 8.3 million shares for $6 each, for a total transaction value of $56 million.

In 2007, Pfizer and Icagen entered an agreement to develop and commercialize pain and other drugs.

Last month Icagen's shares jumped after Pfizer said it was considering a strategic transaction with Icagen. Icagen's shares rose on Tuesday to a year high of $8.40 before closing at $7.75.

At least one analyst had expected the deal value to potentially reach $100 million.

Icagen is developing a pain drug and also an epilepsy drug, which was temporarily put on clinical hold due to an adverse event. The hold was lifted earlier this year.

The companies expect to close the deal before the end of the year.

(Reporting by Toni Clarke, editing by Gerald E. McCormick)

Bladerunner